The price of Edwards Lifesciences Corp (NYSE:EW) shares last traded on Wall Street rose 0.46% to $93.36.
EW stock price is now 14.06% away from the 50-day moving average and 19.33% away from the 200-day moving average. The market capitalization of the company currently stands at $56.14B.
On February 02, 2024, Wells Fargo Upgraded its previous ‘Equal Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $94, while ‘Evercore ISI’ rates the stock as ‘In-line’
In other news, BOBO DONALD E JR, CVP,Strategy/Corp Development sold 14,500 shares of the company’s stock on Mar 13 ’24. The stock was sold for $1,319,696 at an average price of $91.01. Upon completion of the transaction, the CVP,Strategy/Corp Development now directly owns 39,503 shares in the company, valued at $3.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 11 ’24, CVP, EMEACLA and JAPAC Lemercier Jean-Luc M sold 14,400 shares of the business’s stock. A total of $1,320,149 was realized by selling the stock at an average price of $91.68. This leaves the insider owning 173,584 shares of the company worth $16.21 million. A total of 1.58% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $60.57 and a high of $94.87. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 3.38, and a quick ratio of 2.40. According to the stock market information, the enterprise value for the company is $55.19B, which is based on a 40.56 price-to-earnings ratio, a 4.35 price-to-earnings-growth ratio, and a beta of 1.04. The fifty day moving average price for EW is $82.21 and a two-hundred day moving average price translates $78.29 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for Dec, 2023. According to the Medical Devices Company, earnings per share came in at $0.64, inline with analysts’ expectations of $0.64. This compares to $0.65 EPS in the same period last year. The net profit margin was 23.35% and return on equity was 22.52% for EW. The company reported revenue of $1.53 billion for the quarter, compared to $1.35 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.78 percent. For the current quarter, analysts expect EW to generate $1.58B in revenue.
